Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check22 days agoChange DetectedA banner announces an NIH-wide website transition and explains that the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check29 days agoChange DetectedThe site’s displayed software revision was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check36 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history now includes a new revision entry for v3.7.0, superseding v3.6.6. This reflects an update to the study record's documentation in the history section.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page history shows a newer revision label (v3.6.6) replacing the prior v3.6.5, signifying a system update to the study record.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.